Examples of anticoagulants include: warfarin non-vitamin K antagonist oral anticoagulants, also known as direct oral anticoagulants (DOACs) or novel oral anticoagulants (NOACs). These include: ...

The United States Food and Drug Administration (USFDA) (Image Credits: Reuters) The United States Food and Drug Administration (USFDA) has approved the first generics of Xarelto (rivaroxaban ...

Lupin is introducing rivaroxaban tablets, 2.5 mg, which is the generic of Janssen’s Xarelto. The medication is used to reduce the risk of major cardiovascular events in patients with coronary ...

Drug firm Lupin Ltd on Friday (March 7) said it has launched rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (FDA) for its ...

The approval is only for the 2.5mg tablet. The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with ...

In patients undergoing upper gastrointestinal endoscopic submucosal dissection, risk for ischemic stroke was lower with rivaroxaban than with dabigatran. Rivaroxaban was associated with a lower risk ...

In recent years, Factor Xa has emerged as a target for anticoagulant drug development. Rivaroxaban is a selective, oral, direct Factor Xa inhibitor in advanced clinical development for the ...

It’s 8 a.m. and the hospital is starting the day in a tough position. There are 15 patients boarding in the emergency department (ED), two patients who can be downgraded from the intensive care unit, ...

Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.

In the matched cohort, DOAC use (versus warfarin) was associated with a lower rate of ischemic ... We found a lower rate of ischemic stroke or systemic embolism with rivaroxaban (HR, 0.74 [95% CI, ...